Revenue from operations stood at Rs 458.17 crore in third quarter of FY24, registering a growth of 11.94% YoY.

Profit before tax grew by 72.39% year on year to Rs 97.54 crore in the quarter ended 31 December 2023.

Total expenses increased 3% to Rs 385.32 crore in Q3 December 2023 over Q3 December 2022. During the quarter, cost of materials consumed stood at Rs 142.41 crore (up 8.43% YoY) while employee benefits expense was at Rs 103.51 crore (up 8.76% YoY).

On nine-month basis, the company’s consolidated net profit soared 58.54% to Rs 258.94 crore on 9.78% rise in revenue to Rs 1,480.91 crore in 9M FY24 over 9M FY23.

FDC is engaged in manufacturing and marketing of ORS (oral rehydration salts), anti-infectives and ophthalmics.

The counter hit a life time high of Rs 472 in today’s intraday session.